Early detection of blood clotting problems in septic shock
Part of Blood & lymphatic, Infections clinical trials.
This study aims to find early signs of a serious blood-clotting problem that can happen with septic shock. It tests a new way to detect this condition earlier, so doctors can treat it more quickly and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be in the intensive care unit for septic shock (a severe infection that causes dangerously low blood pressure).
- You must be covered by a health insurance plan.
- You (or a family member, if you are too ill) must agree to the study.
- You cannot join if you have severe liver cirrhosis (advanced liver disease), a very low white blood cell count, or if you are pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a blood sample to look at a type of white blood cell that may help doctors identify how serious an infection is early on. By joining, you may help improve how sepsis is detected and treated.
This trial tests a drug called sivelestat to see if it can help people with severe infections who also have blood clotting problems. The drug may reduce the risk of organ damage and improve recovery.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This study tests two new blood tests to see if they can help doctors find sepsis earlier in the emergency department. Sepsis is a serious condition where the body overreacts to an infection, and finding it quickly could lead to faster treatment and better outcomes.
This study looks at two simple blood tests (one for sugar and fat levels, one for inflammation) to see if they can help doctors spot heart problems early in people with septic shock. It might help improve care for future patients.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.